Casma Therapeutics, Inc. and Vipergen ApS announced today the signing of a drug discovery agreement. Under the terms of the agreement, Vipergen will apply its proprietary high-fidelity DNA-encoded...
Casma is a Massachusetts-based biotechnology company that develops therapies for the treatment of cancer, inflammation, neurodegeneration, and metabolic disorders.